[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

IMARC Group: Market Research Reports

The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.

IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.

The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.

Publications found: 10,783
Sort by:

Acute Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major acute pain markets reached a value of US$ 80.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 124.0 Million by 2034, exhibiting a growth rate (CAGR) of 4.03% du...

May 2024 129 pages

Acute Pancreatitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major acute pancreatitis markets reached a value of US$ 695.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,062.9 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 130 pages

Acute Pharyngitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major acute pharyngitis markets reached a value of US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of 4.7%...

May 2024 137 pages

Acute Pyelonephritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major acute pyelonephritis markets reached a value of US$ 183.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 286.4 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 140 pages

Acute Renal Failure Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major acute renal failure markets are expected to exhibit a CAGR of 4.06% during 2024-2034. The acute renal failure market has been comprehensively analyzed in IMARC's new report titled 'Acute R...

May 2024 130 pages

Acute Respiratory Distress Syndrome (ARDS) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major acute respiratory distress syndrome (ARDS) markets are expected to exhibit a CAGR of 10.1% during 2024-2034. The acute respiratory distress syndrome (ARDS) market has been comprehensively...

May 2024 128 pages

Adamantinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major adamantinoma markets reached a value of US$ 900 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,400 Million by 2034, exhibiting a growth rate (CAGR) of 3.99% d...

May 2024 129 pages

Adeno-associated Virus Gene Therapy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major adeno-associated virus gene therapy markets reached a value of US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 75.1 Billion by 2034, exhibiting a growth...

May 2024 129 pages

Adenoid Cystic Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major adenoid cystic carcinoma markets reached a value of US$ 164.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 260.7 Million by 2034, exhibiting a growth rate (CA...

May 2024 132 pages

Adenoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major adenoma markets are expected to exhibit a CAGR of 3.84% during 2024-2034. The adenoma market has been comprehensively analyzed in IMARC's new report titled 'Adenoma Market: Epidemiology, I...

May 2024 138 pages

Adenomatous Polyposis Coli Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major adenomatous polyposis coli markets are expected to exhibit a CAGR of 4.1% during 2024-2034. The adenomatous polyposis coli market has been comprehensively analyzed in IMARC's new report ti...

May 2024 130 pages

Adenosine Deaminase-Severe Combined Immunodeficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major adenosine deaminase-severe combined immunodeficiency markets reached a value of US$ 5.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 11.3 Billion by 2034, exh...

May 2024 137 pages

Adrenal Cortex Neoplasms Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major adrenal cortex neoplasms markets are expected to exhibit a CAGR of 2.15% during 2024-2034. The adrenal cortex neoplasms market has been comprehensively analyzed in IMARC's new report title...

May 2024 129 pages

Adrenoleukodystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major adrenoleukodystrophy markets reached a value of US$ 239.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 290.2 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 133 pages

Adult Myopia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major adult myopia markets reached a value of US$ 177.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 256.9 Million by 2034, exhibiting a growth rate (CAGR) of 3.44%...

May 2024 135 pages

Advanced Heart Failure Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major advanced heart failure markets reached a value of US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 23.9 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 128 pages

Advanced Liver Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major advanced liver cancer markets reached a value of US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 9.6 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 137 pages

Advanced Melanoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major advanced melanoma markets reached a value of US$ 3.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 10.0 Billion by 2034, exhibiting a growth rate (CAGR) of 8.9...

May 2024 130 pages

Advanced Pancreatic Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major advanced pancreatic cancer markets are expected to exhibit a CAGR of 5.79% during 2024-2034. The advanced pancreatic cancer market has been comprehensively analyzed in IMARC's new report t...

May 2024 138 pages

Advanced Renal Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major advanced renal cell carcinoma markets are expected to exhibit a CAGR of 4.53% during 2024-2034. The advanced renal cell carcinoma market has been comprehensively analyzed in IMARC's new re...

May 2024 133 pages

Agammaglobulinemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major agammaglobulinemia markets are expected to exhibit a CAGR of 6.9% during 2024-2034. The agammaglobulinemia market has been comprehensively analyzed in IMARC's new report titled 'Agammaglob...

May 2024 139 pages

Age-Related Macular Degeneration Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major age-related macular degeneration markets reached a value of US$ 10.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 12.0 Billion by 2034, exhibiting a growth ra...

May 2024 128 pages

Age-Related Vision Dysfunction Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major age-related vision dysfunction markets reached a value of US$ 63.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 85.1 Million by 2034, exhibiting a growth rate...

May 2024 139 pages

Agoraphobia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major agoraphobia markets reached a value of US$ 461.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 814.4 Million by 2034, exhibiting a growth rate (CAGR) of 5.3% d...

May 2024 138 pages

AL Amyloidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major AL amyloidosis markets reached a value of US$ 3,374.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 13,300.4 Million by 2034, exhibiting a growth rate (CAGR) o...

May 2024 133 pages

Alagille Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Alagille syndrome markets reached a value of US$ 267.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 435.6 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 135 pages

Alcohol-Related Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major alcohol-related disorders markets reached a value of US$ 667.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,628.6 Million by 2034, exhibiting a growth rate...

May 2024 135 pages

Alcoholic Hepatitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major alcoholic hepatitis markets reached a value of US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.1 Billion by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 129 pages

Allergic Conjunctivitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major allergic conjunctivitis markets reached a value of US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.7 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 136 pages

Allergic Rhinitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major allergic rhinitis markets reached a value of US$ 3,610.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5,078.0 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 130 pages

Alopecia Areata Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major alopecia areata markets are expected to exhibit a CAGR of 6.05% during 2024-2034. The alopecia areata market has been comprehensively analyzed in IMARC's new report titled 'Alopecia Areata...

May 2024 129 pages

Alpha-1 Antitrypsin Deficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major alpha-1 antitrypsin deficiency markets reached a value of US$ 1.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.9 Million by 2034, exhibiting a growth rate (...

May 2024 133 pages

Alpha Thalassemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major alpha thalassemia markets are expected to exhibit a CAGR of 8.06% during 2024-2034. The alpha thalassemia market has been comprehensively analyzed in IMARC's new report titled 'Alpha Thala...

May 2024 131 pages

Alport Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Alport syndrome markets are expected to exhibit a CAGR of 3.46% during 2024-2034. The Alport syndrome market has been comprehensively analyzed in IMARC's new report titled 'Alport Syndrome...

May 2024 138 pages

Alstrom Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Alstrom syndrome markets are expected to exhibit a CAGR of 4.53% during 2024-2034. The Alstrom syndrome market has been comprehensively analyzed in IMARC's new report titled 'Alstrom Syndr...

May 2024 138 pages

Amblyopia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major amblyopia markets reached a value of US$ 3.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.4 Billion by 2034, exhibiting a growth rate (CAGR) of 2.89% during...

May 2024 133 pages

Amebiasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major amebiasis markets reached a value of US$ 17.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 34.9 Billion by 2034, exhibiting a growth rate (CAGR) of 6.53% duri...

May 2024 129 pages

Amnesia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major amnesia markets are expected to exhibit a CAGR of 3.92% during 2024-2034. The amnesia market has been comprehensively analyzed in IMARC's new report titled 'Amnesia Market: Epidemiology, I...

May 2024 134 pages

Amyloid Neuropathies Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major amyloid neuropathies markets are expected to exhibit a CAGR of 4.8% during 2024-2034 The amyloid neuropathies market has been comprehensively analyzed in IMARC's new report titled 'Amyloid...

May 2024 138 pages

Amyloidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major amyloidosis markets reached a value of US$ 5,251.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 20,697.4 Million by 2034, exhibiting a growth rate (CAGR) of 1...

May 2024 135 pages

Anal Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major anal cancer markets reached a value of US$ 633.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,065.9 Million by 2034, exhibiting a growth rate (CAGR) of 4.84...

May 2024 133 pages

Anal Fistula Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major anal fistula markets are expected to exhibit a CAGR of 3.4% during 2024-2034. The anal fistula market has been comprehensively analyzed in IMARC's new report titled 'Anal Fistula Market: E...

May 2024 134 pages

Anaphylaxis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major anaphylaxis markets are expected to exhibit a CAGR of 5.85% during 2024-2034. The anaphylaxis market has been comprehensively analyzed in IMARC's new report titled 'Anaphylaxis Market: Epi...

May 2024 131 pages

Anaplastic Astrocytoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major anaplastic astrocytoma markets reached a value of US$ 1.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1.6 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 133 pages

ANCA Vasculitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ANCA vasculitis markets reached a value of US$ 339.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 534.3 Million by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 128 pages

Andersen Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Andersen disease markets reached a value of US$ 1.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1.8 Billion by 2034, exhibiting a growth rate (CAGR) of 4.76%...

May 2024 130 pages

Androgen Insensitivity Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major androgen insensitivity syndrome markets reached a value of US$ 378.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 633.1 Million by 2034, exhibiting a growth r...

May 2024 133 pages

Androgenetic Alopecia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major androgenetic alopecia markets reached a value of US$ 1,737.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2,637.1 Million by 2034, exhibiting a growth rate (C...

May 2024 136 pages

Anemia in Chronic Kidney Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The anemia in chronic kidney disease market has been comprehensively analyzed in IMARC's new report titled 'Anemia in Chronic Kidney Disease Market: Epidemiology, Industry Trends, Share, Size, Growth,...

May 2024 131 pages

Anemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major anemia markets reached a value of US$ 7.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 12.5 Billion by 2034, exhibiting a growth rate (CAGR) of 4.91% during 2...

May 2024 129 pages

Filters

Search

Categories

2,591
8
343
112
107
17
231
64
26
7
12
3
1
1
243
125
111
3
323
240
20
8
2
86
2
1
1
5
4
567
353
1
227
2
262
326
2
2
7
5
5
5
4
4
3
2
2
2
2
2
1
3
4
2
1
1
2
2
5
20
5
1
1
1
168
12
1
2
1
1
3
8
1,641
1,337
909
28
8
7
6
5
5
5
4
4
3
3
3
3
1
1
1
1
1
1
1

Publishers

10,783

Regions

1
10,741
1
3
5
3
1
25
3

Price

Date

Pages

Offers